Skip to main content
SpringerLink
Log in

Neurophysiology of Micturition: What’s New?

  • Chapter
Continence

  • 890 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. de Groat WC, Booth AM, Yoshimura N. 1993:Neurophysiology of micturition and its modification in animal models of human disease. In: Maggi CA, ed. The autonomic nervous system, Vol. 3, Nervous control of the urogenital system. Harwood Academic Publishers, London: 227–290.

    Google Scholar 

  2. Chai TC, Steers WD. 1996;Neurophysiology of micturition and continence. Urol Clin North Am 23:221–236.

    PubMed  CAS  Google Scholar 

  3. Yoshimura N, de Groat WC. 1997;Neural control of the lower urinary tract. Int J Urol 4:111–125.

    PubMed  CAS  Google Scholar 

  4. de Groat WC. 2006;Integrative control of the lower urinary tract: Preclinical perspective. Br J Pharmacol 147(Suppl 2):S25–40.

    Google Scholar 

  5. Blok BF, Holstege G. 1994;Direct projections from the periaqueductal grey to the pontine micturition centre (M-region). An antegrade and retrograde tracing study in the cat. Neurosci Lett 166:93–96.

    PubMed  CAS  Google Scholar 

  6. Blok BF, de Weerd H, Holstege G. 1995;Ultrastructural evidence for a paucity of projections from lumbosacral cord to the pontine micturition centre or M-region in the cat: A new concept for the organization of the micturition reflex with the periaqueductal grey as central relay. J Comp Neurol 359:300–309.

    PubMed  CAS  Google Scholar 

  7. Blok BF, Willemsen AT, Holstege G. 1997;A PET study on brain control of micturition in humans. Brain 120:(Pt 1)111–121.

    PubMed  Google Scholar 

  8. Blok BF, Sturms LM, Holstege G. 1998;Brain activation during micturition in women. Brain 121:(Pt 11)2033–2042.

    PubMed  Google Scholar 

  9. Nour S, Svarer C, Kristensen JK, et al.2000;Cerebral activation during micturition in normal men. Brain 123:(Pt 4)781–789.

    PubMed  Google Scholar 

  10. Athwal BS, Berkley KJ, Hussain I, et al. 2001;Brain responses to changes in bladder volume and urge to void in healthy men. Brain 124:(Pt 2)369–377.

    PubMed  CAS  Google Scholar 

  11. Matsuura S, Kakizaki H, Mitsui T, et al. 2002;Human brain region response to distention or cold stimulation of the bladder: A positron emission tomography study. J Urol 168:(5)2035–2039.

    PubMed  Google Scholar 

  12. Dasgupta R, Critchley HD, Dolan RJ, Fowler CJ. 2005;Changes in brain activity following sacral neuromodulation for urinary retention. J Urol 174:(6)2268–2272.

    PubMed  Google Scholar 

  13. Zhang H, Reitz A, Kollias S, et al. 2005;An fMRI study of the role of suprapontine brain structures in the voluntary voiding control induced by pelvic floor contraction. Neuroimage 24:(1)174–180.

    PubMed  Google Scholar 

  14. Kavia RB, Dasgupta R, Fowler CJ. 2005;Functional imaging and the central control of the bladder. J Comp Neurol 493:(1)27–32.

    PubMed  Google Scholar 

  15. Griffiths D, Derbyshire S, Stenger A, Resnick N. 2005;Brain control of normal and overactive bladder. J Urol 174:(5)1862–1867.

    PubMed  Google Scholar 

  16. Blok B, Groen J, Veltman D, Bosch R. 2003;Brain plasticity and urge incontinence: PET studies during the first hours of sacral neuromodulation. Neurourol Urodyn 22:490.

    Google Scholar 

  17. Rauch SL, Savage CR, Alpert NM, et al. 1997;Probing striatal function in obsessive-compulsive disorder: A PET study of implicit sequence learning. J Neuropsychiatry Clin Neurosci 9:(4)568–573.

    PubMed  CAS  Google Scholar 

  18. Valet M, Sprenger T, Boecker H, et al. 2004;Distraction modulates connectivity of the cingulo-frontal cortex and the midbrain during pain—An fMRI analysis. Pain 109:(3)399–408.

    PubMed  Google Scholar 

  19. Yoshimura N. 1999;Bladder afferent pathway and spinal cord injury: Possible mechanisms inducing hyperreflexia of the urinary bladder. Prog Neurobiol 57:583–606.

    PubMed  CAS  Google Scholar 

  20. Morrison J, Birder L, Craggs M, et al. 2005:Neural control. In: Abrams P, Cardozo L, Khoury S, Wein A, eds. Incontinence. Health Publications; New Jersey: 363–422.

    Google Scholar 

  21. Leng WW, Chancellor MB. 2005;How sacral nerve stimulation neuromodulation works. Urol Clin North Am 32:(1)11–18.

    PubMed  Google Scholar 

  22. Oliver S, Fowler CJ, Mundy A, Craggs M. 2003;Measuring the sensations of urge and bladder filling during cystometry in urge incontinence and the effects of neuromodulation. Neurourol Urodyn 22:7–16.

    PubMed  Google Scholar 

  23. Aguirre OA. 2006;Acute pudendal nerve stimulation improves cystometric volumes in urge incontinent patients. Int Urogynecol J Pelvic Floor Dysfunct 17:(Suppl. 2)S125 (Abstract 13).

    Google Scholar 

  24. Congregado RB, Pena OXM, Campoy MP, et al.2004;Peripheral afferent nerve stimulation for treatment of lower urinary tract irritative symptoms. Eur Urol 45:65–69.

    Google Scholar 

  25. Dasgupta R, Wiseman OJ, Kitchen N, Fowler CJ. 2004;Long-term results of sacral neuromodulation for women with urinary retention. BJU Int 94:(3)335–337.

    PubMed  Google Scholar 

  26. Michel MC, Oelke M. 2005;Duloxetine in the treatment of stress urinary incontinence. Women’s Health 1:(3)345–358.

    PubMed  CAS  Google Scholar 

  27. de Groat WC, Kawatani M, Hisamitsu T, et al. 1990;Mechanisms underlying the recovery of urinary bladder function following spinal cord injury. J Auton Nerv Syst 30:(Suppl)S71–77.

    PubMed  Google Scholar 

  28. Brady CM, Apostolidis A, Harper M, et al. 2004;Parallel changes in bladder suburothelial vanilloid receptor TRPV1 (VR1) and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity (NDO) following intravesical resiniferatoxin treatment. BJU Int 93:770–776.

    PubMed  CAS  Google Scholar 

  29. Dasgupta P, Chandiramani VA, Beckett A, et al.2000;The effect of intravesical capsaicin on the suburothelial innervation in patients with detrusor hyper-reflexia. BJU Int 85:(3)238–245.

    PubMed  CAS  Google Scholar 

  30. Birder LA, Nakamura Y, Kiss S, et al. 2002;Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat Neurosci 5:(9)856–860.

    PubMed  CAS  Google Scholar 

  31. Cockayne DA, Hamilton SG, Zhu Q-M, et al. 2000;Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 407:1011–1015.

    PubMed  CAS  Google Scholar 

  32. Vlaskovska M, Kasakov L, Rong W, et al. 2000;P2X3 knock-out mice reveal a major sensory role for urothelially released ATP. J Neurosci 21:(15)5670–5677.

    Google Scholar 

  33. Brady C, Apostolidis A, Yiangou Y, et al. 2004;P2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin (RTX). Eur Urol 46:247–253.

    PubMed  CAS  Google Scholar 

  34. Apostolidis A, Popat R, Yiangou Y, et al. 2005;Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibres following intra-detrusor injections of botulinum toxin for human detrusor overactivity. J Urol 174:977–83.

    PubMed  CAS  Google Scholar 

  35. Silva C, Ribeiro MJ, Cruz F. 2002;The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input. J Urol 168:(2)575–579.

    PubMed  CAS  Google Scholar 

  36. Morenilla-Palao C, Planells-Cases R, Garcia-Sanz N, Ferrer-Montiel A. 2004;Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity. J Biol Chem 279:25665–25672.

    PubMed  CAS  Google Scholar 

  37. Burnstock G. 2001;Purine-mediated signalling in pain and visceral perception. Trends Pharmacol Sci 22:182–188.

    PubMed  CAS  Google Scholar 

  38. Guo A, Vulchanova L, Wang J, et al. 1999;Immunocytochemical localization of the vanilloid receptor 1 (VR1): Relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur J Neurosci 11:(3)946–958.

    PubMed  CAS  Google Scholar 

  39. MontellC. 2001;Physiology, phylogeny, and functions of the TRP superfamily of cation channels. Sci STKE 2001:(90)RE1.

    PubMed  CAS  Google Scholar 

  40. Geirsson G. 1993;Evidence of cold receptors in the human bladder: Effect of menthol on the bladder cooling reflex. J Urol 150:(2 Pt 1)427–430.

    PubMed  CAS  Google Scholar 

  41. Lindstrom S, Mazieres L. 1991;Effect of menthol on the bladder cooling reflex in the cat. Acta Physiol Scand 141:(1)1–10.

    PubMed  CAS  Google Scholar 

  42. Fall M, Lindstrom S, Mazieres L. 1990;A bladder-to-bladder cooling reflex in the cat. J Physiol 427:281–300.

    CAS  Google Scholar 

  43. Peier AM, Moqrich A, Hergarden AC, et al. A 2002;TRP channel that senses cold stimuli and menthol. Cell 108:(5)705–715.

    PubMed  CAS  Google Scholar 

  44. McKemy DD, Neuhausser WM, Julius D. 2002;Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 416:(6876)52–58.

    PubMed  CAS  Google Scholar 

  45. Mukerji G, Yiangou Y, Corcoran SL, et al. 2006;Cool and menthol receptor TRPM8 in human urinary bladder disorders and clinical correlations. BMC Urol 6:6.

    PubMed  Google Scholar 

  46. Wakabayashi Y, Tomoyoshi T, Fujimiua M, et al. 1993;Substance P-containing axon terminals in the mucosa of the human urinary bladder: Pre-embedding immunohistochemistry using cryostat sections for electron microscopy. Histochemistry 100:401–407.

    PubMed  CAS  Google Scholar 

  47. Smet PJ, Moore KH, Jonavicius J. 1997;Distribution and colocalization of calcitonin gene-related peptide, tachykinins, and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder. Lab Invest 77:37–49.

    PubMed  CAS  Google Scholar 

  48. De Biasi S, Rustioni A. 1988;Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of spinal cord. Proc Natl Acad Sci USA 85:7820–7824.

    PubMed  CAS  Google Scholar 

  49. Cruz F. 2002;Vanilloid receptor and detrusor instability. Urology 59:(5 Suppl 1)51–60.

    PubMed  Google Scholar 

  50. Avelino A, Cruz F. 2000;Peptide immunoreactivity and ultrastructure of rat urinary bladder nerve fibers after topical desensitization by capsaicin or resiniferatoxin. Auton Neurosci 86:(1–2)37–46.

    PubMed  CAS  Google Scholar 

  51. Maggi CA, Gepetti P, Santicioli P, et al. 1987;The correlation between sensory-efferent functions mediated by the capsaicin-sensitive neurons and substance P content of the urinary bladder of the rat. Neurosci Lett 76:351–356.

    PubMed  CAS  Google Scholar 

  52. Shaker HS, Tu LM, Kalfopoulos M, et al. 1998;Hyperreflexia of the urinary bladder: Possible role of the efferent function of the capsaicin sensitive primary afferents. J Urol 160:(6 Pt 1)2232–2239.

    PubMed  CAS  Google Scholar 

  53. Crowe R, Moss HE, Chapple CR, et al. 1991;Patients with lower motor spinal cord lesion: A decrease of vasoactive intestinal polypeptide, calcitonin gene-related peptide and substance P, but not neuropeptide Y and somatostatin-immunoreactive nerves in the detrusor muscle of the bladder. J Urol 145:600–604.

    PubMed  CAS  Google Scholar 

  54. Kushner L, Chiu PY, Brettschneider N, et al. 2001;Urinary substance P concentration correlates with urinary frequency and urgency in interstitial cystitis patients treated with intravesical dimethyl sulfoxide and not intravesical anesthetic cocktail. Urology 57:(6 Suppl 1)129.

    PubMed  CAS  Google Scholar 

  55. Sukiennik A, Carr DB, Bonney I, et al.2004;The effect of short-term epidural local anesthetic blockade on urinary levels of substance P in interstitial cystitis. Anesth Analg 98:846–850.

    PubMed  CAS  Google Scholar 

  56. Priestley JV, Michael GJ, Averill S, et al. 2002;Regulation of nociceptive neurons by nerve growth factor and glial cell line derived neurotrophic factor. Can J Physiol Pharmacol 80:495–505.

    PubMed  CAS  Google Scholar 

  57. Donnerer J, Amann R, Schuligoi R, Skofitsch G. 1996;Complete recovery by nerve growth factor of neuropeptide content and function in capsaicin-impaired sensory neurons. Brain Res 741:(1–2)103–108.

    PubMed  CAS  Google Scholar 

  58. Burbach GJ, Kim KH, Zivony AS, et al. 2001;The neurosensory tachykinins substance P and neurokinin A directly induce keratinocyte nerve growth factor. J Invest Dermatol 117:1075–1082.

    PubMed  CAS  Google Scholar 

  59. Oh EJ, Gover TD, Cordoba-Rodriguez R, Weinreich D. 2003;Substance P evokes cation currents through TRP channels in HEK293 cells. J Neurophysiol 90:2069–2073.

    PubMed  CAS  Google Scholar 

  60. Ito K, Rome C, Bouleau Y, Dulon D. 2002;Substance P mobilizes intracellular calcium and activates a nonselective cation conductance in rat spiral ganglion neurons. Eur J Neurosci 16:2095–2102.

    PubMed  Google Scholar 

  61. Huang H, Wu X, Nicol GD, et al. 2003;ATP augments peptide release from rat sensory neurons in culture through activation of P2Y receptors. J Pharmacol Exp Ther 306:(3)1137–1144.

    PubMed  CAS  Google Scholar 

  62. Paukert M, Osteroth R, Geisler HS, et al. 2001;Inflammatory mediators potentiate ATP-gated channels through the P2X(3) subunit. J Biol Chem 276:(24)21077–21082.

    PubMed  CAS  Google Scholar 

  63. Persson K, Johansson K, Alm P, et al. 1997;Morphological and functional evidence against a sensory and sympathetic origin of nitric oxide synthase-containing nerves in the rat lower urinary tract. Neuroscience 77:(1)271–281.

    PubMed  CAS  Google Scholar 

  64. Gulbenkian S, Merighi A, Wharton J, et al. 1986;Ultrastructural evidence for the coexistence of calcitonin gene-related peptide and substance P in secretory vesicles of peripheral nerves in the guinea pig. J Neurocytol 15:(4)535–542.

    PubMed  CAS  Google Scholar 

  65. Burnstock G. 1986;The changing face of autonomic neurotransmission. Acta Physiol Scand 126:(1)67–91.

    PubMed  CAS  Google Scholar 

  66. Parsons SM, Prior C, Marshall IG. 1993;Acetylcholine transport, storage, and release. Int Rev Neurobiol 35:279–390.

    PubMed  CAS  Google Scholar 

  67. Gabella G. 1999;Structure of the intramural nerves of the rat bladder. J Neurocytol 28:(8)615–637.

    PubMed  CAS  Google Scholar 

  68. Gabella G. 1995;The structural relations between nerve fibres and muscle cells in the urinary bladder of the rat. J Neurocytol 24:(3)159–187.

    PubMed  CAS  Google Scholar 

  69. Hoyle CH, Burnstock G. 1993:Postganglionic efferent transmission in the bladder and urethra. In: Maggi CA, ed. Nervous control of the urogenital system. Chur, Harwood Academic Publishers, Switzerland: 349–381.

    Google Scholar 

  70. Mukerji G, Yiangou Y, Grogono J, et al. 2006;Localization of M2 and M3 muscarinic receptors in human bladder disorders and their clinical correlations. J Urol 176:(1)367–373.

    PubMed  CAS  Google Scholar 

  71. Pontari MA, Braverman AS, Ruggieri MR, Sr. 2004;The M2 muscarinic receptor mediates in vitro bladder contractions from patients with neurogenic bladder dysfunction. Am J Physiol Regul Integr Comp Physiol 286:(5)R874–880.

    PubMed  CAS  Google Scholar 

  72. Chess-Williams R, Chapple CR, Yamanishi T, et al. 2001;The minor population of M3-receptors mediate contraction of human detrusor muscle in vitro. J Auton Pharmacol 21:(5–6)243–248.

    PubMed  CAS  Google Scholar 

  73. Somogyi GT, Zernova GV, Yoshiyama M, et al. 1998;Frequency dependence of muscarinic facilitation of transmitter release in urinary bladder strips from neurally intact or chronic spinal cord transected rats. Br J Pharmacol 125:241–246.

    PubMed  CAS  Google Scholar 

  74. Chess-Williams R. 2002;Muscarinic receptors of the urinary bladder: Detrusor, urothelial and prejunctional. Auton Autacoid Pharmacol 22:133–145.

    PubMed  CAS  Google Scholar 

  75. Yoshida M, Miyamae K, Iwashita H, et al. 2004;Management of detrusor dysfunction in the elderly: Changes in acetylcholine and adenosine triphosphate release during aging. Urology 63:(Suppl 3A)17–23.

    PubMed  Google Scholar 

  76. Beckel JM, Kanai A, Lee SJ, et al. 2006;Expression of functional nicotinic acetylcholine receptors in rat urinary bladder epithelial cells. Am J Physiol Renal Physiol 290:(1)F103–110.

    PubMed  CAS  Google Scholar 

  77. Birder LA, Kanai AJ, de Groat WC, et al. 2001;Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc Natl Acad Sci USA 98:(23)13396–13401.

    PubMed  CAS  Google Scholar 

  78. Lazzeri M, Vannucchi G, Zardo C, et al. 2004;Immunohistochemical evidence of vanilloid receptor 1 in normal human urinary bladder urothelium. Eur Urol 46:792–799.

    PubMed  CAS  Google Scholar 

  79. Apostolidis A, Brady CM, Yiangou Y, et al. 2005;Capsaicin receptor TRPV1 in the urothelium of neurogenic human bladders and the effect of intravesical resiniferatoxin. Urology 65:400–405.

    PubMed  Google Scholar 

  80. Elneil S, Skepper JN, Kidd EJ, et al. 2001;Distribution of P2X(1) and P2X(3) receptors in the rat and human urinary bladder. Pharmacology 63:(2)120–128.

    PubMed  CAS  Google Scholar 

  81. Lowe EM, Anand P, Terenghi G, et al. 1997;Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol 79:572–577.

    PubMed  CAS  Google Scholar 

  82. Lecci A, Maggi CA. 2001;Tachykinins as modulators of the micturition reflex in the central and peripheral nervous sytem. Regul Pept 101:1–18.

    PubMed  CAS  Google Scholar 

  83. Badawi AF, Habib SL, Mohammed MA, et al. 2002;Influence of cigarette smoking on prostaglandin synthesis and cyclooxygenase-2 gene expression in human urinary bladder cancer. Cancer Invest 20:(5–6)651–656.

    PubMed  CAS  Google Scholar 

  84. Birder LA, Apodaca G, De Groat WC, Kanai AJ. 1998;Adrenergic- and capsaicin-evoked nitric oxide release from urothelium and afferent nerves in urinary bladder. Am J Physiol 275:(2 Pt 2)F226–229.

    PubMed  CAS  Google Scholar 

  85. Moon A. 2002;Influence of nitric oxide signalling pathways on pre-contracted human detrusor smooth muscle in vitro. BJU Int 89:942–949.

    PubMed  CAS  Google Scholar 

  86. Ferguson DR, Kennedy I, Burton T. 1997;ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes – a possible sensory mechanism? J Physiol 505:503–511.

    PubMed  CAS  Google Scholar 

  87. Kumar V, Chapple CR, Chess-Williams R. 2004;Characteristics of adenosine triphosphate release from porcine and human normal bladder. J Urol 172:744–747.

    PubMed  CAS  Google Scholar 

  88. Kennedy C, Leff P. 1995;Painful connection for ATP. Nature 377:385–386.

    PubMed  CAS  Google Scholar 

  89. Birder LA, Barrick SR, Roppolo JR, et al. 2003;Feline interstitial cystitis results in mechanical hypersensitivity and altered ATP release from bladder urothelium. Am J Physiol Renal Physiol 285:(3)F423–429.

    PubMed  CAS  Google Scholar 

  90. Tominaga M, Wada M, Masu M. 2001;Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc Natl Acad Sci USA 98:(12)6951–6956.

    PubMed  CAS  Google Scholar 

  91. Andersson KE. 2004;Antimuscarinics for treatment of overactive bladder. Lancet Neurol 3:47–53.

    Google Scholar 

  92. Khera M, Somogyi GT, Kiss S, et al. 2004;Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem Int 45:987–993.

    PubMed  CAS  Google Scholar 

  93. Yoshida M, Inadome A, Masunaga K, et al. 2004;Non-neuronal acetylcholine and ATP releases from isolated normal and neurogenic human bladder. Neurourol Urodyn 23:(5/6)503–504 (A73).

    CAS  Google Scholar 

  94. Sui GP, Rothery S, Dupont E, et al. 2002;Gap junctions and connexin expression in human suburothelial interstitial cells. BJU Int 90:118–129.

    PubMed  CAS  Google Scholar 

  95. Ost D, Roskams T, Van Der Aa F, deRidder D. 2002;Topography of the vanilloid receptor in the human bladder: More than just the nerve fibers. J Urol 168:293–297.

    PubMed  Google Scholar 

  96. Sui GP, Wu C, Fry CH. 2004;Electrical characteristics of suburothelial cells isolated from the human bladder. J Urol 171:(2 Pt 1)938–943.

    PubMed  CAS  Google Scholar 

  97. Wiseman OJ, Fowler CJ, Landon DN. 2003;The role of the human bladder lamina propria myofibroblast. BJU Int 91:89–93.

    PubMed  CAS  Google Scholar 

  98. Wu C, Sui GP, Fry CH. 2004;Purinergic regulation of guinea pig suburothelial myofibroblasts. J Physiol 559:(Pt 1)231–243.

    PubMed  CAS  Google Scholar 

  99. Roppolo JR, Tai C, Booth AM, et al. 2005;Bladder Adelta afferent nerve activity in normal cats and cats with feline interstitial cystitis. J Urol 173:(3)1011–1015.

    PubMed  Google Scholar 

  100. Keay S, Zhang CO, Shoenfelt JL, Chai TC. 2003;Decreased in vitro proliferation of bladder epithelial cells from patients with interstitial cystitis. Urology 61:(6)1278–1284.

    PubMed  Google Scholar 

  101. Parsons CL, Stein PC, Bidair M, Lebow D. 1994;Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation cystitis. Neurourol Urodyn 13:(5)515–520.

    PubMed  CAS  Google Scholar 

  102. Sun Y, Keay S, De Deyne PG, Chai TC. 2001;Augmented stretch activated adenosine triphosphate release from bladder uroepithelial cells in patients with interstitial cystitis. J Urol 166:(5)1951–1956.

    PubMed  CAS  Google Scholar 

  103. Tempest HV, Dixon AK, Turner WH, et al. 2004;P2X2 and P2X3 receptor expression in human bladder urothelium and changes in interstitial cystitis. BJU Int 93:1344–1348.

    PubMed  CAS  Google Scholar 

  104. Sun Y, Chai TC. 2004;Up-regulation of P2X3 receptor during stretch of bladder urothelial cells from patients with interstitial cystitis. J Urol 171:448–452.

    PubMed  CAS  Google Scholar 

  105. Pang X, Marchand J, Sant GR, et al. 1995;Increased number of substance P positive nerve fibres in interstitial cystitis. Br J Urol 75:(6)744–750.

    PubMed  CAS  Google Scholar 

  106. Marchand JE, Sant GR, Kream RM. 1998;Increased expression of substance P receptor-encoding mRNA in bladder biopsies from patients with interstitial cystitis. Br J Urol 81:(2)224–228.

    PubMed  CAS  Google Scholar 

  107. Onizuka S, Takasaki M, Syed NI. 2005;Long-term exposure to local but not inhalation anesthetics affects neurite regeneration and synapse formation between identified lymnaea neurons. Anesthesiology 102:(2)353–363.

    PubMed  CAS  Google Scholar 

  108. Parsons CL. 2005;Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis. Urology 65:(1)45–48.

    PubMed  Google Scholar 

  109. Lazzeri M, Beneforti P, Spinelli M, et al. 2000;Intravesical resiniferatoxin for the treatment of hypersensitive disorder: A randomized placebo controlled study. J Urol 164:(3 Pt 1)676–679.

    PubMed  CAS  Google Scholar 

  110. Apostolidis A, Gonzales GE, Fowler CJ. Effect of intravesical resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation. Eur Urol 2006.

    Google Scholar 

  111. Mukerji G, Yiangou Y, Agarwal SK, Anand P. 2006;Transient receptor potential vanilloid receptor subtype 1 in painful bladder syndrome and its correlation with pain. J Urol 176:(2)797–801.

    PubMed  CAS  Google Scholar 

  112. Payne CK, Mosbaugh PG, Forrest JB, et al. 2005;Intravesical resiniferatoxin for the treatment of interstitial cystitis: A randomized, double-blind, placebo controlled trial. J Urol 173:(5)1590–1594.

    PubMed  CAS  Google Scholar 

  113. Sant GR, Theoharides TC. 1994;The role of the mast cell in interstitial cystitis. Urol Clin North Am 21:(1)41–53.

    PubMed  CAS  Google Scholar 

  114. Spanos C, el-Mansoury M, Letourneau R, et al. 1996;Carbachol-induced bladder mast cell activation: Augmentation by estradiol and implications for interstitial cystitis. Urology 48:(5)809–816.

    PubMed  CAS  Google Scholar 

  115. Theoharides TC, Kempuraj D, Sant GR. 2001;Mast cell involvement in interstitial cystitis: A review of human and experimental evidence. Urology 57:(6 Suppl 1)47–55.

    PubMed  CAS  Google Scholar 

  116. Nordling J, Anjum FH, Bade JJ, et al. 2004;Primary evaluation of patients suspected of having interstitial cystitis (IC). Eur Urol 45:(5)662–669.

    PubMed  CAS  Google Scholar 

  117. Bouchelouche K, Andresen L, Alvarez S, et al. 2006;Interleukin-4 and -13 induce the expression and release of monocyte chemoattractant protein 1, interleukin-6 and stem cell factor from human detrusor smooth muscle cells: Synergy with interleukin-1beta and tumor necrosis factor-alpha. J Urol 175:(2)760–765.

    PubMed  CAS  Google Scholar 

  118. Bouchelouche K, Alvarez S, Horn T, et al. 2006;Human detrusor smooth muscle cells release interleukin-6, interleukin-8, and RANTES in response to proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha. Urology 67:(1)214–219.

    PubMed  Google Scholar 

  119. Chopra B, Barrick SR, Meyers S, et al. 2005;Expression and function of bradykinin B1 and B2 receptors in normal and inflamed rat urinary bladder urothelium. J Physiol 562:(Pt 3)859–871.

    PubMed  CAS  Google Scholar 

  120. Abrams P, Cardozo L, Fall M, et al. 2002;The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:167–178.

    PubMed  Google Scholar 

  121. Everaert K, De Ridder D, Baert L, et al. 2000;Patient satisfaction and complications following sacral nerve stimulation for urinary retention, urge incontinence and perineal pain: A multicenter evaluation. Int Urogynecol J Pelvic Floor Dysfunct 11:(4)231–235; discussion 236.

    PubMed  CAS  Google Scholar 

  122. Silva C, Silva J, Ribeiro MJ, et al. 2005;Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: Results of a double-blind randomized placebo-controlled trial. Eur Urol 48:(4)650–655.

    PubMed  CAS  Google Scholar 

  123. Kalsi V, Apostolidis A, Gonzales G, et al. 2006;The decline of urgency following intradetrusor botulinum neurotoxin type A (BoNT/A) injections for detrusor overactivity (DO): Preliminary results. Eur Urol 49:(Suppl. 1)A798.

    Google Scholar 

  124. Parsons CL, Dell J, Stanford EJ, et al. 2002;Increased prevalence of interstitial cystitis: Previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology 60:(4)573–578.

    PubMed  Google Scholar 

  125. Andersson KE, Yoshida M. 2003;Antimuscarinics and the overactive detrusor – which is the main mechanism of action? Eur Urol 43:(1)1–5.

    PubMed  CAS  Google Scholar 

  126. Fowler CJ, Harper M, Fry CH. 2002;Voiding and the sacral reflex arc: Lessons from capsaicin instillation. Scand J Urol Nephrol Suppl 210:46–50.

    Google Scholar 

  127. Apostolidis A, Dasgupta P, Fowler CJ. 2006;Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol 49:(4)644–650.

    PubMed  CAS  Google Scholar 

Download references

Acknowldgments

Funding. A. Apostolidis: Pfizer Inc Independent Research Grant; C.J. Fowler: Pfizer Inc Independent Research Grant, Allergan Ltd Unrestricted Educational Health Grant, and Multiple Sclerosis Society of Great Britain and Northern Ireland Research Grant.

Author information

Authors and Affiliations

  1. 2nd Department of Urology, Aristotle University of Thessaloniki, Papageorgiou Hospital, Ring road, Nea Efkarpia, 56403, Thessaloniki, Greece

    Apostolos Apostolidis & Clare J. Fowler

Authors
  1. Apostolos Apostolidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Clare J. Fowler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Clare J. Fowler .

Editor information

Editors and Affiliations

  1. Department of Urology, Wake Forest University Baptist Medical Center, Winston Salem, NC, USA

    Gopal H. Badlani MD

  2. Department of Gynecology, Cleveland Clinic Florida, Weston, FL, USA

    G. Willy Davila MD

  3. Department of Pharmacology and Pharmacotherapy Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

    Martin C. Michel MD, MAE

  4. Department of Urology Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

    Jean J. M. C. H. de la Rosette MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag London Limited

About this chapter

Cite this chapter

Apostolidis, A., Fowler, C. . (2009). Neurophysiology of Micturition: What’s New?. In: Badlani, G.H., Davila, G.W., Michel, M.C., de la Rosette, J.J.M.C.H. (eds) Continence. Springer, London. https://doi.org/10.1007/978-1-84628-510-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-510-3_2

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-510-3

  • Online ISBN: 978-1-84628-734-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation